GS-441524 Injection and Tablets

GS-441524 is a nucleoside analogue studied in feline infectious peritonitis research. This product lists injectable and oral presentations, whose concentration, volume, tablet strength and count should be identified separately.

What ingredient research can explain

Published feline studies have investigated GS-441524 as an antiviral ingredient in defined treatment protocols. Those studies concern particular formulations and veterinary assessment; their outcomes are not a product-quality or efficacy guarantee for every marketed brand.

Injection and tablet specifications

The listed injection is 20 mg/mL in an 8 mL vial. The oral presentations are 20 mg or 40 mg tablets in 12-tablet packs. Milligrams per tablet and milligrams per mL are different measurements, so specify the dosage form before comparing the numbers.

A professionally prescribed formulation

FDA’s reference position on certain compounded GS-441524 products is subject to specific conditions and veterinary prescribing. It is not blanket approval of every vial or brand. An enquiry should identify the actual manufacturer or pharmacy formulation and exact label.

Avoid transferring preparation instructions

Oral and injectable products have separate handling requirements. Keep the product and clinical instructions identified for the animal; published ingredient research or another brand’s instructions are not a home-preparation guide for this listing.